catechin has been researched along with Cardiomyopathies in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (12.50) | 18.7374 |
| 1990's | 1 (12.50) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 4 (50.00) | 24.3611 |
| 2020's | 2 (25.00) | 2.80 |
| Authors | Studies |
|---|---|
| Budde, H; Cimiotti, D; Fujita-Becker, S; Gärtner, A; Hamdani, N; Hassoun, R; Herrmann, C; Jaquet, K; Klingel, K; Krause, V; Laser, KT; Lódi, M; Majchrzak, M; Mannherz, HG; Milting, H; Möhner, D; Mügge, A; Nowaczyk, MM; Pfitzer, G; Schaaf, T; Schröder, RR; Stehle, R; Sultana, I | 1 |
| Govindaraj, S; Muhammed, I; Sankar, S | 1 |
| Gelb, IJ; Huang, X; Jia, Z; Liu, L; Lv, T; Pan, B; Quan, J; Tian, J; Zhang, L; Zhu, J | 1 |
| Chen, TS; Huang, CY; Hung, MY; Kuo, WW; Lin, CC; Lin, HH; Lin, KH; Lin, YM; Liou, SY; Padma, VV; Yao, CH | 1 |
| Andre, F; aus dem Siepen, F; Buss, SJ; Giannitsis, E; Katus, HA; Kristen, AV; Seitz, S; Steen, H | 1 |
| Altland, K; Buss, S; Dengler, TJ; Ehlermann, P; Giannitsis, E; Haberkorn, U; Hardt, S; Katus, HA; Kristen, AV; Lehrke, S; Linke, RP; Mereles, D; Röcken, C; Schnabel, PA; Schreiner, R; Steen, H; Wanker, EE | 1 |
| Bast, A; Boven, E; Grimbergen, JA; Kramer, K; Kuiper, K; van Acker, SA; van den Berg, DJ; van der Vijgh, WJ | 1 |
| Koster, JF; Mostert, LJ; van der Kraaij, AM; van Eijk, HG | 1 |
2 trial(s) available for catechin and Cardiomyopathies
| Article | Year |
|---|---|
Extracellular remodeling in patients with wild-type amyloidosis consuming epigallocatechin-3-gallate: preliminary results of T1 mapping by cardiac magnetic resonance imaging in a small single center study.
Topics: Administration, Oral; Aged; Amyloid; Amyloidosis; Camellia sinensis; Capsules; Cardiomyopathies; Catechin; Contrast Media; Extracellular Matrix; Fibrosis; Gadolinium DTPA; Germany; Humans; Image Interpretation, Computer-Assisted; Magnetic Resonance Imaging, Cine; Male; Myocardium; Plant Extracts; Predictive Value of Tests; Time Factors; Treatment Outcome; Ventricular Remodeling | 2015 |
Green tea halts progression of cardiac transthyretin amyloidosis: an observational report.
Topics: Aged; Amyloid Neuropathies, Familial; Cardiomyopathies; Catechin; Cholesterol; Cohort Studies; Disease Progression; Female; Follow-Up Studies; Heart Ventricles; Humans; Male; Middle Aged; Mitral Valve; Plant Extracts; Tea | 2012 |
6 other study(ies) available for catechin and Cardiomyopathies
| Article | Year |
|---|---|
De Novo Missense Mutations in
Topics: Adenosine Triphosphatases; Adult; Calcium; Cardiomyopathies; Catechin; Humans; Infant; Male; Microscopy, Electron, Transmission; Mutation, Missense; Myofibrils; Sarcomeres; Severity of Illness Index; Simendan; Tropomyosin; Troponin I | 2021 |
Ameliorative Effect of Epigallocatechin Gallate on Cardiac Hypertrophy and Fibrosis in Aged Rats.
Topics: Age Factors; Aging; Animals; Antioxidants; Apoptosis; Cardiomyopathies; Catechin; Disease Models, Animal; Fibrosis; Hypertrophy, Left Ventricular; Lipids; Myocytes, Cardiac; Oxidative Stress; Rats, Wistar; Reactive Oxygen Species; Signal Transduction; Ventricular Function, Left; Ventricular Remodeling | 2018 |
Green tea extract catechin improves cardiac function in pediatric cardiomyopathy patients with diastolic dysfunction.
Topics: Adolescent; Camellia sinensis; Cardiomyopathies; Catechin; Child; Child, Preschool; Echocardiography; Electrocardiography; Female; Humans; Infant; Male; Plant Extracts | 2019 |
Oral administration of green tea Epigallocatechin-3-gallate reduces oxidative stress and enhances restoration of cardiac function in diabetic rats receiving autologous transplantation of adipose-derived stem cells.
Topics: Adipocytes; Adipose Tissue; Administration, Oral; Animals; Blood Glucose; Cardiomyopathies; Catechin; Diabetes Mellitus, Experimental; Echocardiography; Inflammation; Male; Oxidative Stress; Rats; Rats, Wistar; Stem Cell Transplantation; Stem Cells; Tea; Transplantation, Autologous | 2021 |
Monohydroxyethylrutoside, a dose-dependent cardioprotective agent, does not affect the antitumor activity of doxorubicin.
Topics: Animals; Antibiotics, Antineoplastic; Antioxidants; Breast Neoplasms; Cardiomyopathies; Catechin; Chelation Therapy; Cystadenocarcinoma, Serous; Dose-Response Relationship, Drug; Doxorubicin; Drug Interactions; Electrocardiography; Female; Flavonoids; Flavonols; Free Radical Scavengers; Free Radicals; Humans; Hydroxyethylrutoside; Iron; Iron Chelating Agents; Kaempferols; Mice; Mice, Nude; Molecular Structure; Neoplasm Transplantation; Ovarian Neoplasms; Quercetin; Razoxane; Rutin; Telemetry; Tumor Cells, Cultured; Weight Loss | 1997 |
Iron-load increases the susceptibility of rat hearts to oxygen reperfusion damage. Protection by the antioxidant (+)-cyanidanol-3 and deferoxamine.
Topics: Animals; Antioxidants; Cardiomyopathies; Catechin; Coronary Circulation; Deferoxamine; Disease Susceptibility; Glutathione Peroxidase; Hypoxia; Iron; L-Lactate Dehydrogenase; Male; Myocardial Contraction; Myocardium; Oxygen; Rats; Rats, Inbred Strains; Stereoisomerism; Superoxide Dismutase | 1988 |